ALLMedicine™ Hyperkalemia Center
Research & Reviews 2,123 results
https://doi.org/10.1007/s10157-020-02010-7 10.1001/archinternmed.2009.132 10.1093/ndt/gfp104 10.1016/S0272-6386(12)70364-5 10.1152/ajprenal.00104.2007 10.1056/NEJM199909023411001 10.2215/CJN.05850809 10.1159/000329511 10.1159/000437151 10.1371/journal.pone.0067140 10.1093/eurheartj/ehy100 10.1016/j.kint.2016.09.015 10.1007/s10157-019-01838-y 10.1053/j.ajkd.2008.12.034 10.1007/s10157-018-1631-x 10.1681/ASN.2008020159 10.1016/S0749-0704(18)30329-4 10.1001/archinternmed.2009.284 10.2337/dc06-0570 10.1055/s-0031-1295461 10.1056/NEJMoa011161 10.1681/ASN.2006101081 10.1056/NEJMoa053107 10.1186/s12882-019-1228-y 10.1001/archinte.164.6.659 10.1056/NEJM199002083220601 10.1046/j.1523-1755.2001.0590051850.x
Clinical and Experimental Nephrology; Tanaka K, Saito H et. al.
Jan 7th, 2021 - Serum potassium disorders, commonly observed in chronic kidney disease (CKD), are reportedly associated with higher mortality, but their impact on renal outcomes is still controversial. The present study used the longitudinal data of the Fukushima...
https://doi.org/10.1016/j.ijcard.2020.12.081
International Journal of Cardiology; Gallo-Bernal S, Calixto CA et. al.
Jan 7th, 2021 - Hyperkalemia is a potentially life-threatening condition associated with the use of heart failure (HF) medications, which can lead to increased morbidity and mortality. Novel approaches for hyperkalemia prevention are needed, especially in limited...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789484
Critical Care (London, England); Li X, Liu C et. al.
Jan 7th, 2021 - Acute kidney injury (AKI) is a common serious complication in critically ill patients. AKI occurs in up to 50% patients in intensive care unit (ICU), with poor clinical prognosis. Renal replacement therapy (RRT) has been widely used in critically ...
https://doi.org/10.1016/j.ajem.2020.12.029
The American Journal of Emergency Medicine; Bergmann KR, Whitcomb V
Dec 30th, 2020 - Diabetic ketoacidosis (DKA) occurs frequently among children and adolescents with type 1 diabetes. Although a number of complications may occur during episodes of DKA, significant cardiac arrhythmias are uncommon. We present the case of an adolesc...
https://doi.org/10.1111/jocn.15627
Journal of Clinical Nursing; Pack S, Lee J
Dec 30th, 2020 - To develop a smartphone application-based dietary self-management program for hemodialysis patients and to examine its effects on biochemical indicators, self-efficacy, and quality of life. Lack of dietary management in hemodialysis patients can l...
Drugs 169 results see all →
Clinicaltrials.gov 2,571 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90a0a64c-1c98-f27b-e053-2a95a90a8ca5
Jan 11th, 2021 - Hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules...
https://doi.org/10.1007/s10157-020-02010-7 10.1001/archinternmed.2009.132 10.1093/ndt/gfp104 10.1016/S0272-6386(12)70364-5 10.1152/ajprenal.00104.2007 10.1056/NEJM199909023411001 10.2215/CJN.05850809 10.1159/000329511 10.1159/000437151 10.1371/journal.pone.0067140 10.1093/eurheartj/ehy100 10.1016/j.kint.2016.09.015 10.1007/s10157-019-01838-y 10.1053/j.ajkd.2008.12.034 10.1007/s10157-018-1631-x 10.1681/ASN.2008020159 10.1016/S0749-0704(18)30329-4 10.1001/archinternmed.2009.284 10.2337/dc06-0570 10.1055/s-0031-1295461 10.1056/NEJMoa011161 10.1681/ASN.2006101081 10.1056/NEJMoa053107 10.1186/s12882-019-1228-y 10.1001/archinte.164.6.659 10.1056/NEJM199002083220601 10.1046/j.1523-1755.2001.0590051850.x
Clinical and Experimental Nephrology; Tanaka K, Saito H et. al.
Jan 7th, 2021 - Serum potassium disorders, commonly observed in chronic kidney disease (CKD), are reportedly associated with higher mortality, but their impact on renal outcomes is still controversial. The present study used the longitudinal data of the Fukushima...
https://doi.org/10.1016/j.ijcard.2020.12.081
International Journal of Cardiology; Gallo-Bernal S, Calixto CA et. al.
Jan 7th, 2021 - Hyperkalemia is a potentially life-threatening condition associated with the use of heart failure (HF) medications, which can lead to increased morbidity and mortality. Novel approaches for hyperkalemia prevention are needed, especially in limited...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789484
Critical Care (London, England); Li X, Liu C et. al.
Jan 7th, 2021 - Acute kidney injury (AKI) is a common serious complication in critically ill patients. AKI occurs in up to 50% patients in intensive care unit (ICU), with poor clinical prognosis. Renal replacement therapy (RRT) has been widely used in critically ...
https://doi.org/10.1016/j.ajem.2020.12.029
The American Journal of Emergency Medicine; Bergmann KR, Whitcomb V
Dec 30th, 2020 - Diabetic ketoacidosis (DKA) occurs frequently among children and adolescents with type 1 diabetes. Although a number of complications may occur during episodes of DKA, significant cardiac arrhythmias are uncommon. We present the case of an adolesc...
News 347 results
https://www.staging.medscape.com/viewarticle/940012
Oct 28th, 2020 - For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of moderate to severe hyperkalemia, a prespecified analysis of DA...
https://www.medscape.com/viewarticle/940012
Oct 28th, 2020 - For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of moderate to severe hyperkalemia, a prespecified analysis of DA...
https://www.staging.medscape.com/viewarticle/939724
Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...
https://www.medscape.com/viewarticle/939724
Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...
https://www.staging.medscape.com/viewarticle/936725
Sep 3rd, 2020 - Mineralocorticoid receptor antagonists (MRAs) are still finding their place in nephrology. Many of us relegate them to the bottom of our therapeutic bag for use only after we've exhausted other renin-angiotensin-aldosterone (RAAS)-modifying agents...